Antibiotic Gatiflo to be withdrawn from market by Handok

Handok Pharm announced on September 30 that it would stop selling Gatiflo (gatifloxacin), an antibiotic that has been associated with hyperglycemia and hypoglycemia, both of which are potentially fatal blood-sugar disorders.

Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial enzymes DNA gyrase and top...